Form 4: Agilon Health's Chief Technology Officer Reports Stock Disposals for Tax Obligations

Girish Venkatachaliah, Chief Technology Officer of Agilon Health, reports disposals of common stock to cover income tax withholding obligations related to restricted stock units.

Summary

• Girish Venkatachaliah, the Chief Technology Officer of Agilon Health, Inc. (AGL), filed a Form 4 with the SEC on April 16, 2025.
• The filing reports the disposal of 2,808 shares of common stock on April 14, 2025, at a price of $5.6 per share, and 8,226 shares on April 15, 2025, at a price of $5.53 per share.
• These disposals were to satisfy income tax withholding obligations related to the net settlement of restricted stock units and do not represent a sale.
• Following these transactions, Venkatachaliah beneficially owns 266,636 shares of Agilon Health, Inc., including restricted stock units.

Sentiment

Score: 5

Explanation: Neutral sentiment as the filing relates to routine tax obligations and doesn't indicate a change in the executive's overall confidence in the company.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Form 4 filings are required by the SEC to provide transparency regarding insider transactions, allowing investors to monitor the actions of company executives and directors.

Stakeholder Impact

• The stock disposal to cover tax obligations has a minimal impact on shareholders as it is a routine transaction.

Key Dates

Keywords

Form 4, SEC Filing, Stock Disposal, Agilon Health, Venkatachaliah, Restricted Stock Units, Tax Withholding, AGL, Chief Technology Officer